Rituximab Procurement Options: Different Budget Solutions from Originator Drugs to Biosimilars

As Rituximab biosimilars expand the supply landscape alongside originator products, hospitals, pharmacies, and distributors can weigh brand requirements against budget when planning procurement.

Top Stories

Latest Coverage

Oral Medications for Prostate Cancer: How Can Patients Achieve More Structured Home-Based Management?
As prostate cancer treatment continues to evolve, some patients no longer need to rely entirely on treatment administ...
2026 CSCO Guideline Includes Nolgileucel: A Key Development for China-Originated TIL Therapy
On September 17, 2026, the 29th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) opened in Jinan, Ch...
Global PD-1 Competition Heats Up: China Emerges as a Major Force in Cancer Immunotherapy
Over the past decade, PD-1/PD-L1 immune checkpoint inhibitors have reshaped the landscape of cancer treatment. Keytru...
What Professional Services Do Online Pharmacies Provide?
With the development of digital healthcare and pharmaceutical services, online pharmacies are expanding beyond simply...
What Do RET and BRAF Gene Changes Mean in Thyroid Cancer?
What Do RET and BRAF Gene Changes Mean in Thyroid Cancer?
New Drug for Biliary Tract Cancer! A Japanese Innovation Enters China, Adding a New Variable to the Global FGFR Landscape
New Drug for Biliary Tract Cancer! A Japanese Innovation Enters China, Adding a New Variable to the Global FGFR Lands...

In-Depth Analysis


This site uses Just the Docs, a documentation theme for Jekyll.